ClinVar Miner

Submissions for variant NM_000133.4(F9):c.1010C>T (p.Ala337Val)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Coagulation Factor Deficiency Variant Curation Expert Panel, Clingen RCV004577674 SCV005061652 pathogenic Hereditary factor IX deficiency disease 2024-04-26 reviewed by expert panel curation The c.1010C>T (NM_000133.4) variant in F9 is a missense variant predicted to cause substitution of alanine by valine at amino acid 337 (p.Ala337Val). This variant is absent from males in population databases (gnomAD v2.1.1/gnomAD v3). This variant is reported in at least 4 unique probands with mild hemophilia B (PMID: 33760382; PMID: 29296726; PMID: 9450791), meeting phenotypic criteria for F9, including at least one patient with with assumed de novo occurrence (PMID: 9450791). The computational predictor REVEL gives a score of 0.727, which is above the threshold of 0.6, evidence that correlates with impact to F9 function (PP3). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4 + PP4_Moderate + PM2_Supporting + PP3 + PM6. (ClinGen Coagulation Factor Deficiency Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for F9 Version 1.0.0., Released 10/5/2023).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.